# Platform B1 MVP2 Manufacturing and Supply Chain Extension Catalogue

Status: LOCKED CATALOGUE ONLY

This catalogue organizes COBIT-Chain manufacturing and supply-chain extension opportunities without triggering uncontrolled build scope.

It sits under the Platform B1 / MVP2 Priority Scope Lock and the First-Tier Track Registry.

## First-tier tracks

The first-tier tracks remain:

1. Compound Pharmacy
2. IRLT / Radiopharma Operations
3. DSCSA Evidence Integrity & Exception Assurance

These are the priority commercialization and demonstration tracks.

## Purpose

COBIT-Chain should not become MES, LIMS, ERP, eQMS, VRS, EPCIS, ServiceNow, PLC, SCADA, historian, BMS, or a commercial DSCSA network.

COBIT-Chain should evaluate whether evidence, workflow state, identity, authority, AI output, dependency state, and source-system truth can be trusted.

## Manufacturing Execution Assurance

### MES Execution Dependency Assurance

Core question:

MES may show a batch, step, or operation as complete, but do PLC, LIMS, equipment, materials, training, signatures, QMS, ERP, and audit states agree?

Example outputs:

- MES COMPLETE — DEPENDENCY VERIFIED
- MES COMPLETE — DEPENDENCY FAILURE DETECTED
- BATCH COMPLETE BUT NOT RELEASE-READY
- PLC COMPLETION NOT VERIFIED
- QUALITY REVIEW REQUIRED
- RELEASE NOT ADMISSIBLE

### Batch Release Dependency Assurance

Core question:

The batch record appears complete, but is the batch truly reviewable, defensible, and release-ready?

Example outputs:

- BATCH RECORD COMPLETE — RELEASE NOT ADMISSIBLE
- DEVIATION IMPACT REVIEW MISSING
- QUALITY UNIT REVIEW REQUIRED
- RELEASE PACKAGE DEFENSIBLE
- AUDIT TRAIL REVIEW REQUIRED

## Materials, Serialization, and Supply Chain Assurance

### DSCSA Evidence Integrity & Exception Assurance

Priority:

FIRST TIER

Core question:

Can serialized prescription-drug supply-chain evidence be trusted, reconstructed, and defended across EPCIS, VRS, trading-partner handoffs, exception resolution, and AI-assisted triage?

Example outputs:

- DSCSA EVIDENCE SEALED
- HASH VERIFIED
- REHASH REQUIRED
- EPCIS FILE MISMATCH
- VRS RESPONSE MISSING
- CHAIN OF CUSTODY GAP
- DSCSA EXCEPTION DETECTED
- QUARANTINE REQUIRED
- EXCEPTION NOT DEFENSIBLE

### Material Genealogy / ERP / Weigh-and-Dispense Assurance

Core question:

Were the right materials, lots, quantities, statuses, expiry dates, and genealogy used?

Example outputs:

- MATERIAL USED — RELEASE STATUS NOT VERIFIED
- ERP LOT STATUS MISMATCH
- MATERIAL LOT TRACEABLE
- EXPIRY REVIEW REQUIRED
- WEIGHING RECORD OUT OF TOLERANCE

### Packaging / Labeling / Serialization Assurance

Core question:

Were the correct labels, packaging components, serialization events, aggregation records, and reconciliation evidence used?

Example outputs:

- PACKAGING COMPLETE — LABEL VERSION MISMATCH
- SERIALIZATION EVENT VERIFIED
- AGGREGATION CONFLICT
- LABEL RECONCILIATION REQUIRED
- MARKET PACK MISMATCH

## Equipment, Automation, Facility, and Environmental Assurance

### Equipment Readiness / Calibration / PM Assurance

Core question:

Was the equipment fit for GMP use at the time of execution?

Example outputs:

- EQUIPMENT READY
- CALIBRATION EXPIRED
- PM OVERDUE
- EQUIPMENT ON HOLD
- CHANGE CONTROL REVIEW REQUIRED

### Automation / PLC / SCADA / Historian Truth Assurance

Core question:

Does automation evidence support the manufacturing record?

Example outputs:

- MES STEP COMPLETE — HISTORIAN EVIDENCE CONFLICT
- PLC COMPLETION VERIFIED
- SCADA ALARM REVIEW REQUIRED
- MANUAL OVERRIDE REVIEW REQUIRED
- CRITICAL PARAMETER OUT OF RANGE

### Utilities / Environmental Monitoring Assurance

Core question:

Were the facility, utilities, room state, and environmental conditions acceptable during execution?

Example outputs:

- ENVIRONMENTAL STATE ACCEPTABLE
- ROOM PRESSURE EXCURSION REVIEW REQUIRED
- BMS ALARM REVIEW REQUIRED
- UTILITY STATUS NOT VERIFIED
- BATCH EXECUTED — ENVIRONMENTAL EXCURSION REVIEW REQUIRED

## Quality, Cleaning, Aseptic, Recipe, and Process Assurance

### Cleaning / Line Clearance / Changeover Assurance

Core question:

Was the line, room, equipment, and process state truly ready for the next operation?

Example outputs:

- LINE CLEARED
- PRIOR PRODUCT CLEARANCE EVIDENCE MISSING
- CLEANING RECORD INCOMPLETE
- HOLD TIME EXCEEDED
- QA VERIFICATION REQUIRED

### Recipe / Master Data / MBR / BOM Assurance

Core question:

Was the right approved manufacturing recipe, BOM, parameter set, and master data used?

Example outputs:

- RECIPE VERSION VERIFIED
- BATCH EXECUTED — RECIPE VERSION NOT ALIGNED WITH APPROVED MBR
- BOM VERSION MISMATCH
- CPP CQA LIMIT REVIEW REQUIRED
- MASTER DATA CONFLICT

### Aseptic / Sterility Assurance

Core question:

Can aseptic manufacturing conditions be defended?

Example outputs:

- ASEPTIC OPERATION COMPLETE — INTERVENTION REVIEW MISSING
- STERILIZATION CYCLE VERIFIED
- FILTER INTEGRITY REVIEW REQUIRED
- EM RESULT REVIEW REQUIRED
- MEDIA FILL QUALIFICATION REQUIRED

### Manufacturing Deviation Impact Assurance

Core question:

Did this manufacturing event impact the batch, equipment, material, process, facility, release decision, or patient-risk posture?

Example outputs:

- DEVIATION CLOSED — BATCH IMPACT NOT DEFENSIBLE
- BATCH IMPACT ASSESSED
- REPEAT EVENT REVIEW REQUIRED
- CAPA LINK MISSING
- QUALITY REVIEW REQUIRED

## Lifecycle, CPV, and External Manufacturing Assurance

### Tech Transfer / PPQ / Continued Process Verification Assurance

Core question:

Did knowledge, controls, parameters, and evidence transfer correctly from development to manufacturing and remain controlled during CPV?

Example outputs:

- PROCESS TRANSFERRED — CONTROL STRATEGY EVIDENCE GAP
- PPQ EVIDENCE COMPLETE
- CPV SIGNAL REVIEW REQUIRED
- PROCESS DRIFT DETECTED
- DIGITAL TWIN ASSUMPTION REVIEW REQUIRED

### CMO / External Manufacturing Assurance

Core question:

Can a sponsor trust external manufacturing evidence from a CMO or CDMO?

Example outputs:

- CMO PACKAGE RECEIVED — RELEASE EVIDENCE INCOMPLETE
- QUALITY AGREEMENT RESPONSIBILITY VERIFIED
- CMO DEVIATION PACKAGE INCOMPLETE
- DATA INTEGRITY EVIDENCE REQUIRED
- RELEASE RESPONSIBILITY REVIEW REQUIRED

## Cross-cutting AI governance

AI may assist, classify, summarize, route, recommend, and prepare evidence.

AI may not independently approve, release, override quarantine, replace Quality Unit review, replace source-system truth, or execute regulated actions without accountable human governance.

Required controls:

- AI agent identity
- model and prompt version
- approved context of use
- input source traceability
- tool-call evidence
- human reviewer
- Quality Unit accountability where applicable
- hash of AI output
- rehash status when source evidence changes
- recommendation-versus-execution boundary

Example outputs:

- AI RECOMMENDATION REVIEW REQUIRED
- AI CONTEXT NOT APPROVED
- AI OUTPUT HASHED
- MODEL VERSION RECORDED
- HUMAN REVIEW REQUIRED
- QUALITY REVIEW REQUIRED
- AGENT ACTION NOT ADMISSIBLE

## Shared COBIT-Chain foundation

Every extension must preserve:

- hashing
- rehashing
- evidence integrity
- chain-of-custody truth
- workflow dependency assurance
- action admissibility
- regulated operations digital twin
- governed AI
- RAMAT Vision / Thread D2 display
- official records remain in source systems

## Global boundary

Catalogue only.

Do not modify Platform B v1.

Do not reopen Thread D v1.

Do not activate MVP3.

Do not build full commercial integrations now.

Use mock-data-first, simulator-first, local-validation-first implementation.

Do not use real ServiceNow production data.

Do not use real LIS, MES, ERP, eQMS, VRS, EPCIS, or GMP production data.

Do not use PHI.

Do not use company production data.

Platform B1 evaluates.

Thread D2 displays.

## Next order of work

1. Create DSCSA Evidence Integrity & Exception Assurance addendum.
2. Create Compound Pharmacy commercialization addendum.
3. Create IRLT / Radiopharma Operations first-tier addendum.
4. Create shared Regulated Operations Digital Twin object model.
5. Build first DSCSA mock scenario only after scope documents are locked.
